BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2016
View Archived Issues
ZIOPHARM plans phase I study of CD33 CAR T-cell therapy
Read More
MJFF, van Andel Research and Cure Parkinson's Trust to study nilotinib in Parkinson's disease
Read More
IntelGenx starts phase I trial of montelukast for the treatment of neurodegenerative diseases
Read More
Oncodesign launches phase 0/I trial for ODS-2004436 radiotracer
Read More
Mutations in TRMT10C identified as a cause of mitochondrial disease
Read More
Aptinyx starts dosing in phase I trial for NYX-2925
Read More
Merck & Co. patents BTK inhibitors
Read More
OncoArendi Therapeutics describes arginase inhibitors
Read More
King's College London discloses retinoid RARbeta receptor agonists
Read More
Revlimid approved in Europe for relapsed or refractory MCL
Read More
Hitgen reports HDAC inhibitors
Read More
NovoBiotic Pharmaceuticals receives grant from NIAID to advance teixobactin program
Read More
Dethree Res, J-Pharma and Nippon Chemiphar present URAT1 inhibitors
Read More
Update on U.S. regulatory filing for Raxone in Duchenne muscular dystrophy
Read More
Juno Therapeutics acquires RedoxTherapies
Read More
Boehringer Ingelheim announces collaboration with the University of Dundee
Read More
Three organizations merge to form Lupus Research Alliance
Read More
ArmaGen presents data on AGT-182 for Hunter syndrome
Read More
GSK exercises option under respiratory disease collaboration with Five Prime
Read More
Plex Pharmaceuticals obtains funding to develop compounds for Parkinson's disease
Read More
NTRK2 shows promise as a therapeutic target for astrocytoma
Read More
Disruption of TRIP8b-HCN interaction may induce antidepressant-like behavior
Read More
Tyrosine kinase inhibitor shows promise in Parkinson's disease patients
Read More
FDA advisory committee recommends approval of biosimilar etanercept
Read More
New panel shows promise for infection diagnosis
Read More
An RYR1 mutation is associated with bleeding abnormalities
Read More
NIH expands investment to advance basic medical research toward HIV cure
Read More